In vitro, CXCL1 stimulated the proliferation, invasion, and migration of breast cancer cells while inhibiting apoptosis, which seems to partially explain the unfavorable prognosis of patients with overexpression of this chemokine [18,32]. The gene discussed is CXCL1; the disease is breast cancer.